Replies to post #17136 on Rich Pharmaceuticals Inc. (fka RCHA)

[Pstats]

Dr. McCoy L. Moretz has been the Chairman, Chief Executive Officer and Chief Medical Officer at Mega Bridge Inc. since June 28, 2017 and has been its Chief Financial Officer since July 11, 2017. Dr. Moretz is the founder of F.A.C.E of Beverly Hills and has been its Principal Surgeon since 2006. He served as the Chief Medical Officer of Ermis Labs; and Advisor to Torii Labs. He served as a Member of Medical Advisory Board at Rich Pharmaceuticals, Inc., assisted with the development and expansion of its clinical sites and in the development of protocols. Dr. Moretz is a board certified surgeon with more than 23 years of experience. He has operated successful private practices in Atlanta, Georgia and Beverly Hills, California. He is an internationally renowned cosmetic surgeon. Board Certified by the ABO, a member of the American Board of Medical Specialties, Dr. Moretz is a Fellow of the American College of Surgeons; American Board of Otolaryngology/Head & Neck Surgery; American Academy of Facial Plastic & Reconstructive surgery; American Academy of Cosmetic Surgery; and American Academy of Otolaryngology/Head & Neck Surgery. He has been involved with numerous Clinical Investigations over the past decade and has authored prestigious medical publications in the Archives of Otolaryngology. Dr. Moretz graduated with a BA in chemistry from the University of North Carolina in 1978; received his Medical Degree from the Medical College of Georgia, 1982 (with Honors) and completed his internship at Emory University Hospital in Atlanta, Georgia in 1983.